Please Enable Cookies

www.laserfocusworld.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Recent Quotes
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment

By: MarketWatch
Crispr Therapeutics and Vertex Pharmaceuticals got U.S. regulatory approval for a sickle-cell disease treatment based on the gene-editing technology Crispr.
Related Stocks:
Bluebird Bio Crispr Therapeutics Ag Editas Medicine Vertex Pharmaceuticals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.